Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Genprex

MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) at Forefront to Advance Innovative Developments in Fight Against Lung Cancers

Clinical-stage gene-therapy company Genprex (NASDAQ: GNPX) is at the forefront to advance innovative developments in the war against lung cancers, testing its trademarked Oncoprex immunogene therapy. A recent article discussing this reads, “Oncoprex’s phase I and II clinical-stage trial therapies … Continue reading

Posted in Genprex, MissionIRNewsBreaks | Leave a comment